Sources and Guidelines Referenced

This clinical guide incorporates recommendations and evidence from the following professional societies and studies: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease; 2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease; Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (2022); EVEREST II Randomized Clinical Trial (Feldman et al., NEJM 2011); COAPT Pivotal Trial (Stone et al., NEJM 2018); MITRA-FR Trial (Obadia et al., NEJM 2018); TRILUMINATE Pivotal Trial (Sorajja et al., NEJM 2023).

Heart Valve Repair (Mitral/Tricuspid): A Comprehensive Patient Guide

1. Definition and Medical Identity

Heart valve repair is a cardiovascular procedure that restores normal mechanical function to damaged mitral or tricuspid valves without replacing them with artificial prostheses. Performed via open cardiac surgery, minimally invasive incisions, or transcatheter delivery, its clinical goal is to eliminate blood regurgitation, preserve native ventricular architecture, and restore healthy circulatory dynamics.

The procedure is formally classified under cardiovascular surgical interventions and structural heart interventional cardiology. The mitral valve sits between the left atrium and left ventricle, controlling oxygenated blood flow destined for the body. The tricuspid valve lies between the right atrium and right ventricle, managing deoxygenated blood Returning from systemic circulation. When these valves leak—a condition termed valvular regurgitation or valve incompetence—blood flows backward into the preceding heart chamber during muscular contraction. Repair procedures correct structural defects in the valve flaps, anchor cords, or supporting ring to re-establish tight closure during cardiac contraction.

2. The Underlying Condition or Need

Heart valve repair treats valvular insufficiency caused by degenerative tissue deterioration, functional dilation secondary to heart failure, or infectious destruction. Without repair, severe regurgitation causes progressive volume overload, forcing the heart muscle to enlarge and weaken over time. This untreated disease pathway leads to irreversible heart failure, severe cardiac arrhythmias, pulmonary hypertension, and elevated mortality risk.

Under normal conditions, heart valves act as passive one-way check valves. In degenerative mitral valve disease, such as myxomatous degeneration or Barlow disease, tissue weakness causes the valve leaflets to bulge backward into the upper chamber, known as leaflet prolapse. If tissue cords break, a flail leaflet results, causing severe backward leakage. In functional valve disease, the cardiac chamber enlarges following a heart attack or chronic cardiomyopathy. This enlargement pulls the valve leaflets apart, preventing them from meeting in the middle. Symptoms include progressive shortness of breath during exertion (dyspnoea), persistent fatigue, swelling in the lower extremities (peripheral oedema), rapid or irregular heartbeats (palpitations), and reduced exercise capacity. According to the 2020 ACC/AHA guidelines, intervention is indicated before irreversible heart muscle weakness or permanent lung pressure elevation develops.

3. How the Treatment Works — Mechanism

Heart valve repair works by physically reshaping, reinforcing, or realigning native valve tissue so the flexible flaps meet properly during heart contraction. The procedure restores an adequate area of leaflet coaptation, which is the surface contact zone where valve flaps press together to block backward blood flow. This mechanical restoration relieves volume overload on the heart chambers.

The precise mechanism depends on the biological defect present. When the supporting valve ring, called the annulus, expands, surgeons sew an artificial stabilizing ring around its perimeter. This procedure, known as annuloplasty, reduces the diameter of the valve opening and forces the leaflets back into contact. When supportive fibrous cords (chordae tendineae) are stretched or torn, surgeons implant synthetic PTFE cords to re-anchor the leaflet edge to the internal heart muscle. If excessive tissue causes leaflet bulging, surgeons remove triangular segments of damaged tissue and sew the edges together. In minimally invasive transcatheter procedures, a mechanical device clips the center points of opposing leaflets together, creating a functional dual-orifice valve that dramatically reduces leakage while maintaining forward flow.

4. Types and Variations

Heart valve repair techniques vary based on anatomical approach, surgical tool set, and whether open surgical access or transcatheter delivery is selected. Clinical teams select the ideal repair strategy by evaluating structural valve pathology, patient operative risk scores, and overall health status.

Surgical approaches include full median sternotomy, minimally invasive mini-thoracotomy, and robot-assisted cardiac surgery. Transcatheter approaches bypass the need for open surgery entirely, delivering repair devices through blood vessels. The table below outlines major clinical variations.

5. Who the Treatment Is For — Indications

Heart valve repair is indicated for patients with severe, symptomatic mitral or tricuspid valve regurgitation, as well as asymptomatic patients showing early signs of left or right heart enlargement or strain. Objective clinical thresholds established by international guidelines determine precise intervention timing.

Specific clinical indications defined by the 2020 ACC/AHA and 2021 ESC/EACTS guidelines include:

• Symptomatic severe primary mitral regurgitation: Patients with exertional dyspnoea, fatigue, or reduced exercise tolerance who have preserved left ventricular function.
• Asymptomatic severe primary mitral regurgitation: Patients without symptoms who exhibit left ventricular enlargement (left ventricular end-systolic diameter ≥ 40 mm) or reduced ejection fraction (LVEF ≤ 60%).
• Secondary (functional) mitral regurgitation: Patients with persistent symptoms despite optimal medical therapy for heart failure, as demonstrated in the landmark COAPT trial (Stone et al., NEJM 2018).
• Severe tricuspid regurgitation: Patients undergoing left-sided valve surgery who also exhibit tricuspid annular dilation (≥ 40 mm) or severe tricuspid leak.
• New-onset atrial fibrillation or pulmonary hypertension: Patients with severe degenerative mitral leak who develop pulmonary artery systolic pressure > 50 mmHg at rest.

6. Who the Treatment Is NOT For — Contraindications

Heart valve repair is contraindicated when valve tissue is severely calcified, destroyed, or anatomically unsuitable for structural restoration. In such cases, attempting repair carries a high failure rate, making prosthetic valve replacement the clinically safer option.

Absolute and relative contraindications include:

• Severe Valvular Calcification: Dense calcium deposits involving the leaflets or annulus prevent flexible movement and suture placement, making successful repair impossible.
• Rheumatic Valve Disease with Severe Fibrosis: Rheumatic fever causes extensive leaflet fusion and shortening, which frequently leads to repeat stenosis or leakage after repair attempts.
• Active Uncontrolled Endocarditis: Severe bacterial infection causing wide tissue destruction usually requires complete removal of the valve structure and replacement with an artificial prosthesis.
• Inadequate Leaflet Tissue Area: Secondary regurgitation with extreme leaflet tethering and displacement prevents leaflets from reaching one another despite annuloplasty.
• Extreme Comorbid Fragility (for Surgical Repair): Patients with severe end-stage co-existing organ failures may be medically unsuitable for open cardiac surgery and cardiopulmonary bypass, directing care toward transcatheter options or palliative medical therapy.

7. Alternatives and Clinical Comparison

Alternatives to heart valve repair include long-term medical therapy, surgical heart valve replacement, and transcatheter valve replacement. While medical therapy controls symptoms of fluid overload, it cannot fix structural mechanical valve defects.

Surgical replacement replaces native tissue with either a mechanical artificial valve or a biological tissue valve from a donor animal. The choice between repair, replacement, and medical management depends on anatomical suitability, operative risk, and long-term anticoagulation considerations.

8. Pre-Treatment Phase

The pre-treatment phase involves extensive diagnostic imaging, physiological risk stratification, and patient preparation to ensure precise surgical planning and optimal safety. A multidisciplinary Heart Team, consisting of cardiologists, cardiac surgeons, imaging specialists, and anaesthetists, evaluates every case.

The diagnostic workup begins with a transthoracic echocardiogram (TTE) to assess overall heart performance, followed by a transesophageal echocardiogram (TEE). TEE involves placing a specialized ultrasound probe into the oesophagus, providing crystal-clear images of valve leaflets, chordae, and regurgitant jet mechanisms. Coronary angiography is performed to check for blocked heart arteries that might require simultaneous coronary bypass grafting. Pre-operative blood testing evaluates kidney function, liver function, complete blood count, and coagulation profiles. Patients undergo dental screening to locate and treat active oral infections, preventing bacteria from migrating to the heart. Blood-thinning medications and anti-platelet drugs are adjusted several days before the procedure under medical direction.

9. The Procedure — Step-by-Step Clinical Detail

Heart valve repair follows a meticulous, highly structured intraoperative sequence tailored to whether an open surgical or transcatheter approach is utilized. Both techniques require specialized cardiac monitoring, including continuous transesophageal ultrasound guidance.

The standard clinical steps for open surgical mitral valve repair include:

1. Anaesthesia and Monitoring: The patient receives general anaesthesia. Central venous lines, arterial blood pressure lines, and a TEE probe are placed.
2. Surgical Access: The chest is opened via a conventional middle sternum incision (median sternotomy) or a small side chest incision (right mini-thoracotomy).
3. Cardiopulmonary Bypass: Cannulas are inserted into major blood vessels to connect the patient to a heart-lung machine. The machine temporarily takes over breathing and circulation, allowing the surgeon to work on a stationary heart.
4. Cardioplegia Administration: A cold chemical solution is infused into the cardiac arteries to safely pause heart contractions and protect the muscle during surgery.
5. Atrial Incision and Inspection: The upper heart chamber is opened, exposing the damaged valve. The surgeon inspects the leaflets, chordae, and ring structure under magnification.
6. Surgical Reconstruction: The surgeon performs targeted structural repair, such as placing synthetic PTFE artificial chordae, trimming prolapsed leaflet segments, or adding tissue patches.
7. Annuloplasty Ring Placement: A cloth-covered rigid or semi-rigid ring is sewn around the valve boundary to resize the ring and secure long-term durability.
8. Saline Testing and De-airing: The ventricle is filled with pressurized saline solution to visually verify valve tightness. Air is meticulously removed from the heart chambers.
9. Weaning from Bypass and Re-warming: Blood flow is restored to the heart, which resumes beating. The patient is gradually transitioned off the heart-lung machine.
10. Echocardiographic Verification and Closure: TEE confirms complete valve competence with no residual leak. Chest tubes are placed to drain fluid, and the surgical site is closed.

For transcatheter edge-to-edge repair (TEER), access is gained through the femoral vein in the groin. Under fluoroscopic and TEE guidance, a delivery catheter is advanced into the right atrium, across the atrial septum, and into the left ventricle. The clip device grasps the loose leaflet edges, pulling them together to stop regurgitation before the delivery catheter is withdrawn.

10. Immediate Post-Procedure Period

Immediately following surgical repair, the patient is transferred to the Intensive Care Unit (ICU) under continuous hemodynamic, respiratory, and cardiac rhythm monitoring. Early management focuses on optimizing blood pressure, controlling pain, and smoothly transitioning the patient off mechanical ventilation.

The patient typically remains intubated for several hours until awake and hemodynamically stable. Supplemental oxygen, chest tube drainage rates, and urine output are carefully recorded. Pain management uses intravenous opioids alongside non-opioid medications to allow comfortable deep breathing and coughing, which prevents lung collapse (atelectasis). Early physical therapy begins on post-operative day one, assisting the patient to sit up and walk short distances. Rhythm monitoring is critical because temporary heart rhythm disturbances, particularly atrial fibrillation, occur in up to 30% of post-cardiac surgery patients according to STS database metrics. Patients transition from the ICU to a step-down telemetry unit once stable.

11. Recovery — Short and Long Term

Recovery from heart valve repair progresses over several stages, moving from inpatient care to structured outpatient cardiac rehabilitation. Full physical recovery from open chest surgery typically takes six to twelve weeks, whereas recovery from transcatheter procedures takes one to two weeks.

The recovery timeline follows this general sequence:

• Inpatient Phase (Days 1 to 5): Gradual removal of chest drains, urinary catheters, and intravenous lines. Progression from fluid diet to solid foods. Walking independently in corridors.
• Early Home Recovery (Weeks 1 to 3): Continuation of daily walking exercises. Avoidance of lifting anything heavier than 5 to 10 pounds (2.5–4.5 kg) to protect the healing breastbone. Drivers must abstain from driving until cleared by their surgeon.
• Intermediate Recovery (Weeks 4 to 8): Enrollment in a medically supervised cardiac rehabilitation program involving monitored exercise, nutritional guidance, and risk factor modification.
• Long-Term Recovery (Months 2 to 6): Gradual return to full physical activity, including sport, travel, and employment. Sternal bone healing is typically complete by week 12.

12. Risks, Side Effects, and Complications

While heart valve repair carries high success rates in specialized centers, all cardiovascular procedures carry inherent risks. Complications range from self-limiting side effects to life-threatening events that require immediate emergency treatment.

Surgical risk is quantified pre-operatively using standardized society scoring systems, such as the STS Risk Score. Factors influencing risk include advanced age, low ejection fraction, chronic kidney disease, and urgency of surgery. The table below stratifies clinical risks by frequency and severity.

13. Lifestyle and Behavioural Considerations

Optimizing health habits before and after heart valve repair enhances recovery speed, reduces complication rates, and protects overall cardiovascular function. Lifestyle adjustments are an essential component of post-procedure care.

Pre-procedure optimization includes absolute tobacco cessation, which reduces pulmonary complications and surgical site infections. Nutrition should focus on a heart-healthy diet low in sodium to manage fluid balance and blood pressure. Patients taking anticoagulant medications must follow strict dietary guidelines regarding Vitamin K intake. Regular physical activity, structured through formal cardiac rehabilitation, speeds functional recovery. Good oral hygiene and routine dental care are mandatory for life to prevent bacterial seeding onto the repaired valve—a dangerous condition called infective endocarditis.

14. How Outcomes Are Measured

Clinical success following heart valve repair is measured by immediate residual leakage, long-term valve durability, heart chamber remodeling, and improvements in patient functional capacity and overall survival.

The principal clinical endpoints evaluated include:

• Echocardiographic Regurgitation Grade: Regurgitation is graded from 0 (none) to 4+ (severe). A successful repair reduces regurgitation to trace or mild (Grade 1+ or less).
• Ventricular Remodeling: Serial ultrasound scans measure whether enlarged left and right heart chambers contract back toward normal dimensions over the 12 months following surgery.
• NYHA Functional Class: Patient symptoms are categorized using the New York Heart Association (NYHA) scale from Class I (no limitations) to Class IV (severe symptoms at rest). Successful repair typically restores patients to Class I or II.
• Freedom from Re-operation: Large clinical registries indicate that freedom from re-operation following surgical degenerative mitral valve repair exceeds 90% at 10 years and 80% at 20 years (STS Database 2022).

15. Recent Advances and Current Standard of Care

The standard of care for heart valve repair has evolved significantly through minimally invasive techniques, 3D echocardiographic imaging, and dedicated transcatheter devices. These technological advances allow precise repairs in patients previously considered unsuitable for open surgery.

Modern surgical repair emphasizes native tissue preservation over tissue resection, using pre-measured synthetic ePTFE loops to recreate chordae. Minimally invasive video-assisted mini-thoracotomy and robotic surgical systems allow complex repairs through small incisions between the ribs, reducing surgical trauma, pain, and hospital recovery times. Transcatheter therapies have expanded rapidly: transcatheter edge-to-edge repair (TEER) is now well-established for both mitral and tricuspid valves based on landmark randomized trials like COAPT (Stone et al., NEJM 2018) and TRILUMINATE (Sorajja et al., NEJM 2023). Advanced 3D transesophageal imaging allows real-time structural guidance inside the beating heart.

16. Common Myths and Misconceptions

Myth: Valve replacement is superior to valve repair because a brand-new valve is installed.
Reality: Surgical guidelines explicitly state that valve repair is superior to replacement whenever feasible. Repair preserves native heart muscle function, delivers better long-term survival, and avoids the risks of mechanical prosthetic blood clots or biological valve degeneration (2020 ACC/AHA Guidelines).

Myth: Every patient with a heart valve leak needs immediate open heart surgery.
Reality: Mild or moderate regurgitation is often monitored safely with regular physical exams and yearly echocardiograms. Surgery is indicated only when specific severity thresholds, heart enlargement markers, or symptoms develop.

Myth: Once a valve is repaired, blood thinners must be taken for life.
Reality: Unlike mechanical valve replacement, successful valve repair does not require lifelong blood thinners like warfarin. Most repair patients take blood thinners for only a few weeks to months, or not at all if they remain in normal sinus rhythm.

Myth: Minimally invasive valve repair is less effective than conventional open surgery.
Reality: Published multi-center study data confirm that minimally invasive and robotic valve repair techniques achieve identical repair quality, safety, and long-term durability compared to full open sternotomy when performed by experienced teams.

Myth: Tricuspid valve leaks are harmless and do not require treatment.
Reality: Chronic severe tricuspid regurgitation leads to right heart failure, liver dysfunction, kidney impairment, and elevated long-term mortality. Modern guidelines advocate timely intervention for severe tricuspid leak.

Myth: Elderly patients are automatically too old for valve repair procedures.
Reality: Chronological age alone is not a barrier. Modern transcatheter repair techniques like TEER allow severe valve leaks in elderly or fragile patients to be safely corrected through a small vein access point in the groin.

17. Frequently Asked Questions

What is the difference between mitral valve repair and mitral valve replacement?

Mitral valve repair preserves your natural heart tissue by fixing damaged structures, such as reshaping the valve opening or replacing torn support cords. Mitral valve replacement removes your native valve entirely and replaces it with a mechanical or biological artificial valve. Guidelines prefer repair because it protects long-term heart function and avoids lifetime blood thinners.

How long does a surgical heart valve repair last?

Surgical mitral valve repair offers exceptional long-term durability. STS registry data indicate that over 90% of patients with degenerative valve disease do not require re-operation within 10 years of surgery, and over 80% remain free of re-intervention at 20 years. Regular echocardiograms monitor valve stability over time.

Can a tricuspid valve be repaired at the same time as a mitral valve?

Yes. Combined mitral and tricuspid valve repair is common practice. When surgeons operate on the mitral valve, they routinely examine the tricuspid valve. If the tricuspid ring is dilated or leaking significantly, placing a tricuspid annuloplasty ring during the same operation prevents progressive right-sided heart failure.

What is transcatheter edge-to-edge repair (TEER)?

TEER is a minimally invasive procedure that treats valve leakage without open heart surgery. A small tube is guided through a vein in your groin up to your heart. Under ultrasound guidance, a small mechanical clip attaches the loose valve leaflets together, reducing backflow while allowing forward blood flow.

Is open heart surgery required for all valve repairs?

No. While standard surgical repair uses a chest incision, many patients qualify for minimally invasive surgical repair performed through a tiny incision between the ribs. Alternatively, high-risk or elderly patients may undergo percutaneous transcatheter repair through the blood vessels in the groin.

How long will I stay in the hospital after valve repair?

Hospital stays typically range from 4 to 7 days following open heart or minimally invasive surgery. Patients spend 1 to 2 days in the ICU before moving to a standard nursing floor. Patients undergoing transcatheter edge-to-edge repair are often discharged within 1 to 2 days.

When can I drive again after valve repair surgery?

If your procedure involved opening the breastbone (sternotomy), driving is restricted for approximately 4 to 6 weeks. This restriction prevents sternal bone movement and allows reaction time to recover. Patients undergoing transcatheter repair can usually resume driving within 1 to 2 weeks.

Will I need blood-thinning medication after valve repair?

Most valve repair patients do not require long-term blood thinners like warfarin. Following surgical repair, mild blood thinners or aspirin may be prescribed for 1 to 3 months until healing is complete, unless you have pre-existing atrial fibrillation requiring continuous therapy.

What are the warning signs of complications after returning home?

Contact your care team immediately if you experience sudden shortness of breath, a rapid or irregular heartbeat, unexplained fever over 100.4°F (38°C), rapid weight gain of more than 2 to 3 pounds in 24 hours, swelling in your legs, or redness and drainage at your incision site.

Can a heart valve leak again after being repaired?

Re-leakage can happen if heart disease progresses or if native tissue degrades further over time. However, severe recurrent leakage occurs in fewer than 10% to 15% of patients over a 10-year period. Serial annual echocardiograms monitor your valve to detect any changes early.

How soon can I return to work after valve repair?

Return-to-work timelines depend on your job requirements and the surgical approach used. Office workers undergoing minimally invasive or transcatheter repair may return within 2 to 4 weeks. Those recovering from open chest surgery or working physically demanding jobs typically require 8 to 12 weeks off.

Is dental work restricted before or after valve repair?

Yes. Dental clearance is mandatory before surgery to eliminate hidden sources of mouth bacteria that could cause heart infections. After repair, prophylactic antibiotics are recommended before certain invasive dental procedures during the initial post-repair healing phase to prevent endocarditis.

What is annuloplasty?

Annuloplasty is a core repair technique where an artificial cloth-covered ring or band is sewn around the base of the heart valve. This ring resizes and reinforces the enlarged valve opening, enabling the valve flaps to meet closely again and stop leakage.

What is the difference between primary and secondary regurgitation?

Primary regurgitation is caused by a physical defect in the valve tissue itself, such as stretched cords or floppy leaflets. Secondary (functional) regurgitation occurs when an enlarged or damaged heart muscle pulls healthy valve leaflets apart, preventing them from closing tightly.